YU39973B - Process for obtaining n-aryl-n-(4-piperidinyl)-arylacetamides - Google Patents
Process for obtaining n-aryl-n-(4-piperidinyl)-arylacetamidesInfo
- Publication number
- YU39973B YU39973B YU2336/76A YU233676A YU39973B YU 39973 B YU39973 B YU 39973B YU 2336/76 A YU2336/76 A YU 2336/76A YU 233676 A YU233676 A YU 233676A YU 39973 B YU39973 B YU 39973B
- Authority
- YU
- Yugoslavia
- Prior art keywords
- arylacetamides
- piperidinyl
- aryl
- obtaining
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61513175A | 1975-09-23 | 1975-09-23 | |
US71375676A | 1976-08-12 | 1976-08-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
YU233676A YU233676A (en) | 1983-01-21 |
YU39973B true YU39973B (en) | 1985-06-30 |
Family
ID=27087421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU2336/76A YU39973B (en) | 1975-09-23 | 1976-09-22 | Process for obtaining n-aryl-n-(4-piperidinyl)-arylacetamides |
Country Status (29)
Country | Link |
---|---|
JP (1) | JPS6016417B2 (en) |
AT (1) | AT363935B (en) |
AU (1) | AU510029B2 (en) |
BG (1) | BG27543A3 (en) |
CA (1) | CA1068271A (en) |
CH (1) | CH628623A5 (en) |
CS (1) | CS222663B2 (en) |
DE (1) | DE2642856A1 (en) |
DK (1) | DK150478C (en) |
ES (1) | ES451768A1 (en) |
FI (1) | FI61482C (en) |
FR (1) | FR2325377A1 (en) |
GB (1) | GB1539473A (en) |
GR (1) | GR58469B (en) |
HU (1) | HU172964B (en) |
IE (1) | IE43802B1 (en) |
IL (1) | IL50522A (en) |
IT (1) | IT1073893B (en) |
LU (1) | LU75837A1 (en) |
NL (1) | NL187267C (en) |
NO (1) | NO147672C (en) |
NZ (1) | NZ181972A (en) |
PH (1) | PH12497A (en) |
PL (2) | PL117323B1 (en) |
PT (1) | PT65631B (en) |
RO (1) | RO70079A (en) |
SE (1) | SE427839B (en) |
SU (1) | SU747424A3 (en) |
YU (1) | YU39973B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA765684B (en) * | 1975-09-23 | 1978-04-26 | Janssen Pharmaceutica Nv | Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides |
JPS62260786A (en) * | 1986-05-08 | 1987-11-13 | 株式会社ヘキトク | Line system for manufacturing smoked roof tile |
JO2769B1 (en) | 2005-10-26 | 2014-03-15 | جانسين فارماسوتيكا ان. في | Fast Dissociting Dopamine 2 Receptor Antagonists |
JO2642B1 (en) | 2006-12-08 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Fast Dissociating Dopamine 2 Receptor Antagonists |
JO2849B1 (en) | 2007-02-13 | 2015-03-15 | جانسين فارماسوتيكا ان. في | Fast -Dissociating Dopamine 2 Receptor Antagonists |
AU2008240727C1 (en) * | 2007-04-23 | 2013-10-03 | Janssen Pharmaceutica N.V. | Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists |
CN101663292A (en) | 2007-04-23 | 2010-03-03 | 詹森药业有限公司 | 4-alkoxypyridazine derivatives as quick dissociated dopamine 2 receptor antagonists |
CA2682671C (en) | 2007-04-23 | 2015-11-17 | Janssen Pharmaceutica N.V. | Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists |
CN102159554B (en) | 2008-07-03 | 2014-09-24 | 詹森药业有限公司 | Substituted 6- (1-piperazinyl) -pyridazines as 5-ht6 receptor antagonists |
LT2307374T (en) | 2008-07-31 | 2017-04-25 | Janssen Pharmaceutica Nv | Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists |
-
1976
- 1976-09-06 NO NO763054A patent/NO147672C/en unknown
- 1976-09-08 NZ NZ181972A patent/NZ181972A/en unknown
- 1976-09-16 FR FR7627870A patent/FR2325377A1/en active Granted
- 1976-09-17 AU AU17878/76A patent/AU510029B2/en not_active Expired
- 1976-09-20 LU LU75837A patent/LU75837A1/xx unknown
- 1976-09-20 RO RO7687590A patent/RO70079A/en unknown
- 1976-09-20 CA CA261,551A patent/CA1068271A/en not_active Expired
- 1976-09-21 IL IL50522A patent/IL50522A/en unknown
- 1976-09-21 GR GR51742A patent/GR58469B/en unknown
- 1976-09-21 GB GB39099/76A patent/GB1539473A/en not_active Expired
- 1976-09-21 CH CH1194876A patent/CH628623A5/en not_active IP Right Cessation
- 1976-09-21 IT IT51370/76A patent/IT1073893B/en active
- 1976-09-21 JP JP51112527A patent/JPS6016417B2/en not_active Expired
- 1976-09-22 PH PH18928A patent/PH12497A/en unknown
- 1976-09-22 NL NLAANVRAGE7610513,A patent/NL187267C/en not_active IP Right Cessation
- 1976-09-22 PL PL1976216213A patent/PL117323B1/en unknown
- 1976-09-22 ES ES451768A patent/ES451768A1/en not_active Expired
- 1976-09-22 PL PL19257876A patent/PL192578A1/en not_active IP Right Cessation
- 1976-09-22 CS CS766139A patent/CS222663B2/en unknown
- 1976-09-22 AT AT0702976A patent/AT363935B/en not_active IP Right Cessation
- 1976-09-22 SE SE7610501A patent/SE427839B/en not_active IP Right Cessation
- 1976-09-22 YU YU2336/76A patent/YU39973B/en unknown
- 1976-09-22 DK DK427876A patent/DK150478C/en active
- 1976-09-22 FI FI762698A patent/FI61482C/en not_active IP Right Cessation
- 1976-09-22 HU HU76JA00000767A patent/HU172964B/en not_active IP Right Cessation
- 1976-09-22 PT PT65631A patent/PT65631B/en unknown
- 1976-09-22 IE IE2095/76A patent/IE43802B1/en unknown
- 1976-09-23 SU SU762405548A patent/SU747424A3/en active
- 1976-09-23 BG BG034265A patent/BG27543A3/en unknown
- 1976-09-23 DE DE19762642856 patent/DE2642856A1/en active Granted
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU262076A (en) | Process for obtaining 2-phenyl-3-aroylbenzothiophene | |
HU174396B (en) | Process for preparing 17-alpha-hydroxy-corticosteroids | |
YU140576A (en) | Process for obtaining nifamycin compounds | |
YU39077A (en) | Process for obtaining sulfonyl-benzimidazole compounds | |
YU248076A (en) | Process for obtaining new 1-benzazolylalkyl-4-substituted piperidines | |
YU100676A (en) | Process for obtaining piperazinylpyrazine | |
YU147976A (en) | Process for obtaining 11-deoxy-16-aryloxy-omega-tetranoprostaglandin | |
GB1548032A (en) | Process for preparing amono-acid admides | |
HU175022B (en) | Process for preparing 11-deoxy-acetylene-aryl-prostaglandins | |
YU39973B (en) | Process for obtaining n-aryl-n-(4-piperidinyl)-arylacetamides | |
GB1554153A (en) | Process for making 2-amino-2-alkylthionitroethylenes | |
HU174650B (en) | Process for preparing l-piroglutamyl-l-prolinamide | |
YU121176A (en) | Process for obtaining rifamcin compounds | |
YU196776A (en) | Process for obtaining phosphor-dichlorido-thiolate | |
YU45476A (en) | Process for obtaining 2-oxo-pyrrolidinyl ecetamide | |
GB1542488A (en) | Process for preparing alpha-amino-gamma-methylmercaptobutyronitrile | |
YU94182A (en) | Process for obtaining 6-alkoxy-alpha-carboxy-penicillin | |
HU174888B (en) | Process for preparing 1-naphthyl-n-methyl-carbamate | |
YU262276A (en) | Process for obtaining aroyl-phenyl naphthalines | |
HU175729B (en) | Process for preparing fluoro-prostaglandins | |
HU174777B (en) | Process for preparing 2-acylamino-oxazoles | |
HU172553B (en) | Process for producing -3-acyloxymethyl-cepheme- and -3-thiomethyl-cepheme- derivatives | |
IL50682A0 (en) | Process for preparing dihalovinylcyclopropanecarboxylates | |
HU174633B (en) | Process for preparing glycol-aldehyde | |
HU174667B (en) | Process for preparing omega-amino-alkane-carbonyl-aryl-amides |